Ironwood Pharmaceuticals, Inc.
Status: Publicly traded
Direct answer
Ironwood Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker IRWD.
Ironwood Pharmaceuticals, Inc. operates as a healthcare enterprise primarily dedicated to discovering, developing, and commercializing therapeutic solutions for gastrointestinal (GI) conditions. Its flagship commercial product is linaclotide, a guanylate cyclase type-C (GC-C) agonist. This medication is prescribed for adult patients managing irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic...
Can you invest in Ironwood Pharmaceuticals, Inc.?
Yes. Ironwood Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker IRWD.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Ironwood Pharmaceuticals, Inc.
Detailed equity research is provided by MarketSnap.